This report studies the global Anti-Peptic Ulcer Drugs market status and forecast, categorizes the global Anti-Peptic Ulcer Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/global-anti-peptic-ulcer-drugs-sales-market-report-2018
China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China’s homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China’s healthcare needs are set to rise sharply in the coming years.
In April 2015, China amended its Drug Administration Law, introducing two major changes.
The first is a simplification of the company set-up procedure for pharmaceutical companies. Prior to the amendment, investors that wanted to manufacture or distribute pharmaceuticals needed to have a Drug Manufacturing License or a Drug Distribution License before applying for a business license. Now, investors may apply for these after the company has been set up, significantly speeding up the incorporation process.
More importantly, the amendment removes the price controls that the Chinese government had in place for medicines. As of the year 2000, medicines that were listed on the government’s Medical Insurance Catalog, and those medicines on which there was a monopoly, had their prices fixed or guided by the government. About 23 percent of the medicines on the Chinese market had government fixed or guided prices. The price of other medicines was left to market forces. While these price restrictions are now fully removed, companies still need to abide by China’s anti-trust laws. Companies abusing their dominant market position are still punishable under Chinese law.
While recent moves have made it easier for foreign investors to introduce new medical products to the Chinese market, the Chinese government has at the same time placed restraints on advertising healthcare products. The final text of the revised Advertising Law was released by the National People’s Congress, China main legislative body, in late April 2015. The law comes into force in September 2015.
The 2015 Advertising Law has special stipulations about advertising for medicine and medical devices. For one, advertising for anesthetics, psychotropic drugs, toxic and radioactive drugs for medical use is not allowed, nor is advertisement for drugs, treatment plans and medical devices to combat drug addiction. Advertising for prescription drugs other than those mentioned previously is only allowed in professional medical journals.
The content for medical advertisements is regulated as well. Any advertisement for drugs, medical treatment or medical devices may not contain the following:
The global Anti-Peptic Ulcer Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018–2025.
The major players covered in this report
- AstraZeneca
- Ask-pharm
- Takeda
- Yangtze River Pharm
- Shandong Luoxin
- Huadong Medicine
- Changzhou Siyao
- Beijing Yuekang
- Guangdong Dahua
- Xian Janssen
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Proton Pump Inhibitors (PPIs)
- Potassium-Competitive Acid Blockers (P-CAB)
- Antacids
- H2 Antagonists
- Ulcer Protective Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
- Gastritis
- Gastric Ulcers
- Duodenal Ulcers
- Gastroesophageal Reflux Disease (GERD)
The study objectives of this report are:
- To analyze and study the global Anti-Peptic Ulcer Drugs sales, value, status (2013–2017) and forecast (2018–2025);
- To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
- Focuses on the key Anti-Peptic Ulcer Drugs players, to study the sales, value, market share and development plans in future.
- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Anti-Peptic Ulcer Drugs are as follows:
- History Year: 2013–2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
- Anti-Peptic Ulcer Drugs Manufacturers
- Anti-Peptic Ulcer Drugs Distributors/Traders/Wholesalers
- Anti-Peptic Ulcer Drugs Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
Available Customizations
- With the given market data, We offers customizations according to the company’s specific needs. The following customization options are available for the report:
- Regional and country-level analysis of the Anti-Peptic Ulcer Drugs market, by end-use.
- Detailed analysis and profiles of additional market players.
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/global-anti-peptic-ulcer-drugs-sales-market-report-2018
Table of content
Global Anti-Peptic Ulcer Drugs Sales Market Report 2018
1 Anti-Peptic Ulcer Drugs Market Overview
1.1 Product Overview and Scope of Anti-Peptic Ulcer Drugs
1.2 Classification of Anti-Peptic Ulcer Drugs by Product Category
1.2.1 Global Anti-Peptic Ulcer Drugs Market Size (Sales) Comparison by Type (2013–2025)
1.2.2 Global Anti-Peptic Ulcer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Proton Pump Inhibitors (PPIs)
1.2.4 Potassium-Competitive Acid Blockers (P-CAB)
1.2.5 Antacids
1.2.6 H2 Antagonists
1.2.7 Ulcer Protective Drugs
1.3 Global Anti-Peptic Ulcer Drugs Market by Application/End Users
1.3.1 Global Anti-Peptic Ulcer Drugs Sales (Volume) and Market Share Comparison by Application (2013–2025)
1.3.1 Gastritis
1.3.2 Gastric Ulcers
1.3.3 Duodenal Ulcers
1.3.4 Gastroesophageal Reflux Disease (GERD)
2 Global Anti-Peptic Ulcer Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Anti-Peptic Ulcer Drugs Market Competition by Players/Suppliers
2.1.1 Global Anti-Peptic Ulcer Drugs Sales and Market Share of Key Players/Suppliers (2013–2018)
2.1.2 Global Anti-Peptic Ulcer Drugs Revenue and Share by Players/Suppliers (2013–2018)
2.2 Global Anti-Peptic Ulcer Drugs (Volume and Value) by Type
2.2.1 Global Anti-Peptic Ulcer Drugs Sales and Market Share by Type (2013–2018)
2.2.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Type (2013–2018)
2.3 Global Anti-Peptic Ulcer Drugs (Volume and Value) by Region
If You Have Any Question Related To This Report Contact Us @ https://www.24marketreports.com/enquire-now/global-anti-peptic-ulcer-drugs-sales-market-report-2018
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: help@24marketreports.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports